Zobrazeno 1 - 10
of 58
pro vyhledávání: '"J M, HILDEN"'
Publikováno v:
Journal of Pediatric Hematology/Oncology. 18:182-186
Purpose : Patients treated for Hodgkin disease (HD) are at increased risk for developing secondary neoplasms, including non-Hodgkin lymphoma (NHL). We present a patient who developed NHL (brain and lungs) as a second malignancy together with recurren
Publikováno v:
Blood. 82:1080-1085
The chromosomal translocation, t(4;11)(q21;q23), is the most common type of 11q23 chromosomal abnormality, being highly prevalent in infant acute leukemias and associated with a poor prognosis. The t(4;11) results in the fusion of an 11q23 gene (MLL,
Autor:
Rukhmi Bhat, Alan S. Gamis, John D. Crispino, J M Hilden, Sébastien Malinge, Rhett P. Ketterling, Martin S. Tallman, Elisabeth Paietta, April D. Sorrell
Publikováno v:
Leukemia. 23:2159-2160
Publikováno v:
Medical and pediatric oncology. 30(3)
Medullary dysplasia may be present in the kidneys of children with the Beckwith-Wiedemann Syndrome (BWS). This is usually visible only at the microscopic level, but superimposed pyelonephritis in a child with the BWS led to gross changes that produce
Autor:
J M, Hilden, F O, Smith, J L, Frestedt, R, McGlennen, W B, Howells, P H, Sorensen, D C, Arthur, W G, Woods, J, Buckley, I D, Bernstein, J H, Kersey
Publikováno v:
Blood. 89(10)
To study prognostic factors in infant acute myeloid leukemia (AML), we analyzed 44 children treated on Childrens Cancer Group protocols for MLL gene rearrangement by Southern blot, cytogenetic 11q23 abnormalities, and reactivity with monoclonal antib
Publikováno v:
Blood. 86(10)
Molecular techniques to detect MLL (11q23) and AF-4 (4q21) gene rearrangements are being evaluated for use in stratification of patients into prognostic groups. We studied 15 cases of infant acute lymphoblastic leukemia (ALL) with Southern blotting f
Publikováno v:
Journal of Clinical Oncology. 25:12507-12507
12507 Background: Atypical teratoid/rhabdoid tumor (AT/RT) is a highly malignant tumor of the central nervous system (CNS) in childhood, comprising up to 20% of malignant CNS tumors in patients < 3 years old. Although aggressive approaches including
Autor:
D. A. Singer, J. M. Hilden, J. Finklestein, E. Sandler, K. W. Chan, K. M. Shannon, E. Mantadakis
Publikováno v:
Journal of Pediatric Hematology/Oncology. 20:377
Autor:
J M, HILDEN
Publikováno v:
Ugeskrift for laeger. 123
Autor:
Geller JI; Division of Pediatric Oncology, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, USA., Renfro LA; Division of Biostatistics, University of Southern California and Children's Oncology Group, Los Angeles, California, USA., Grundy PE; Division of Immunology, Hematology, Oncology, Palliative Care, and Environmental Interactions, University of Alberta, Edmonton, Alberta, Canada., Perlman EJ; Department of Pathology and Laboratory Medicine, Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Kalapurakal JA; Department of Radiation Oncology, Northwestern University, Chicago, Illinois, USA., Ehrlich PF; Section of Pediatric Surgery, CS Mott Children's Hospital, University of Michigan, Ann Arbor, Michigan, USA., Biegel J; Keck School of Medicine, University of Southern California, Los Angeles, California, USA.; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, California, USA., Huff V; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Warwick AB; Department of Pediatrics, F. Edward Hébert School of Medicine, Uniformed Services University, Bethesda, Maryland, USA., Paulino A; MD Anderson Cancer Center, Houston, Texas, USA., Mullen EA; Boston Children's Hospital and Dana Farber Cancer Institute, Boston, Massachusetts, USA., Daw NC; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hoffer FA; Department of Radiology, Fred Hutchison Cancer Center, University of Washington, Seattle, Washington, USA., Tochner Z; Department of Radiation Oncology, Perelman Center for Advanced Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA., Gow K; Division of Pediatric General and Thoracic Surgery, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA., Gratias E; eviCore Healthcare, Bluffton, South Carolina, USA., Ward DA; Department of Pharmaceutical Services, St. Jude Children's Research Hospital, Memphis, Tennessee, USA., Anderson JR; University of Nebraska Medical Center, Omaha, Nebraska, USA., Fernandez CV; Division of Pediatric Hematology Oncology, IWK Health Centre, Dalhousie University, Halifax, Nova Scotia, Canada., Dome JS; Division of Oncology, Children's National Hospital and Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, District of Columbia, USA.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Dec 19, pp. e31490. Date of Electronic Publication: 2024 Dec 19.